{"text_format":"3","workbook":"xls","n_sheets":3,"sheets":["Sheet1","Sheet2","Sheet3"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":23,"n_cols":6,"rows_kept":23,"merged":[[1,0,2,0],[1,1,1,2],[1,3,2,3],[1,4,1,5],[2,1,2,2],[2,4,2,5]],"flags":["formulas_cached_only"]}
["Supp Table 3. Adverse Events in Patients With Wild-Type KRAS Exon 2 mCRC"]
[null,"Panitumumab Plus BSC",null,null,"BSC alone"]
[null,"(n=189)",null,null,"(n=188)"]
[null,"Any grade","Grade 3/4",null,"Any grade","Grade 3/4"]
["Any grade AE (≥10% in either arm; italicized terms have ≥5% difference between arms)"]
["Rash","73 (38.6)","11 (5.8)",null,"2 (1.1)","0 (0.0)"]
["Dermatitis acneiform","54 (28.6)","11 (5.8)",null,"0 (0.0)","0 (0.0)"]
["Hypomagnesemia","53 (28.0)","11 (5.8)",null,"2 (1.1)","1 (0.5)"]
["Pruritus","47 (24.9)","4 (2.1)",null,"0 (0.0)","0 (0.0)"]
["Abdominal pain","29 (15.3)","4 (2.1)",null,"20 (10.6)","8 (4.3)"]
["Dry skin","29 (15.3)","0 (0.0)",null,"1 (0.5)","0 (0.0)"]
["Fatigue","28 (14.8)","4 (2.1)",null,"15 (8.0)","4 (2.1)"]
["Paronychia","27 (14.3)","0 (0.0)",null,"0 (0.0)","0 (0.0)"]
["Acne","26 (13.8)","3 (1.6)",null,"0 (0.0)","0 (0.0)"]
["Diarrhea","25 (13.2)","1 (0.5)",null,"7 (3.7)","1 (0.5)"]
["Erythema","23 (12.2)","0 (0.0)",null,"0 (0.0)","0 (0.0)"]
["Palmar-plantar erythrodysesthesia syndrome","19 (10.1)","0 (0.0)",null,"0 (0.0)","0 (0.0)"]
["Additional adverse events with ≥5% difference between arms"]
["Conjunctivitis","12 (6.3)","2 (1.1)",null,"0 (0.0)","0 (0.0)"]
["Stomatitis","12 (6.3)","0 (0.0)",null,"0 (0.0)","0 (0.0)"]
["Hypocalcemia","13 (6.9)","2 (1.1)",null,"1 (0.5)","0 (0.0)"]
["Rash maculopapular","10 (5.3)","1 (0.5)",null,"0 (0.0)","0 (0.0)"]
["BSC, best supportive care; mCRC, metastatic colorectal cancer."]

{"sheet":"Sheet2","index":1,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}

{"sheet":"Sheet3","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"flags":["formulas_cached_only"]}